Enable Injections
@EnableInjection
Enable's body-worn enFuse® drug delivery technology delivers large volumes via SC administration. *Approved in the U.S. in combination with a specific drug.
You might like
A recent publication in @AAPSComms explores the challenges and opportunities in developing high-concentration subcutaneous biologic formulations: lnkd.in/egHs3MZm At Enable, we’re bridging the gap between formulation science and delivery innovation. #drugdelivery
Thank you to everyone who visited our booth at the PDA Universe of Pre-Filled Syringes and Injection Devices Conference 2025! Our team enjoyed meeting you and demonstrating the innovative enFuse® On-Body Delivery System. Contact us to learn more: lnkd.in/eKacC7Xp
We are excited to announce a new partnership with Incyte to develop and commercialize specific assets in Incyte’s portfolio with the enFuse® On-Body Delivery System! Learn more here: bit.ly/3Wp7zmA
Between the pipeline of talent, economic incentives, and the wide network of support across the #lifesciences ecosystem, Enable Injections is proud to call #Cincinnati home! Read more about this growing industry in the region from the @BusinessCourier: lnkd.in/gkxDt6NU
#KidneyWk, hosted by the American Society of Nephrology (ASN) is only a month away! If you’re attending, stop by Booth 202 for a demonstration of our enFuse system or contact us to set up a meeting: lnkd.in/eKacC7Xp #DrugDelivery #largevolume #enFuse
#PODD2025 is only a month away! If you’re attending, stop by Booth 701 for a demonstration of our enFuse system or contact us to set up a meeting: lnkd.in/eKacC7Xp #DrugDelivery #largevolume #subcutaneousdelivery #enFuse
Be sure to catch our session “Addressing Large-Volume Subcutaneous Delivery Challenges with enFuse: A Patient- and Provider-Centric Solution” at PDA Universe of Pre-Filled Syringes and Injection Devices Conference 2025, Oct 21. #PDA #drugdelivery #enFuse
Are you ready to make an impact and create meaningful change in a growing company and in the lives of patients? Check out the opportunity here: lnkd.in/gEWjAZP2 #Hiring #enFuse
The future of patient care lies not only in the drugs we discover, but in how we deliver them. The latest edition of @ONdrugDelivery is here, focusing on wearable injectors and featuring the innovative enFuse drug delivery system! Read the full article: bit.ly/3K3EMB8
We’re excited to announce the enFuse System has been approved by Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria or ANVISA)! . Read the full announcement here: bit.ly/45wJnmi #enFuse #drugdelivery #subcu
By allowing mobility during administration, the enFuse empowers patients to live their normal lives while receiving their medication. Learn more about the enFuse on our website: enableinjections.com #enFuse #drugdelivery #subcutaneous #selfadministration #innovativetechnology
The U.S. FDA has approved Apellis Pharmaceuticals’ treatment for complement 3 glomerulopathy (C3G) and primary immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN), severe and rare kidney diseases, for patients 12 and older: lnkd.in/gjAMgT2T
Why is SC delivery a game-changer for biopharma? Download our whitepaper to discover how wearable technology can simplify drug delivery while also potentially reducing burden on healthcare systems and improving safety & efficacy: lnkd.in/g62UNpXN #drugdelivery #enFuse
We’re proud to announce the enFuse Syringe Transfer System is now registered in the UK! This registration comes after the enFuse recently received CE Mark approval in the EU. We look forward to bringing our technology to patients around the world! #drugdelivery #enFuse
Discover how #subcutaneousdelivery unlocks value and drives sales growth in our white paper published by @FierceBiotech: lnkd.in/g62UNpXN Learn how switching from IV to SC #drugdelivery can be a viable, effective and low risk way to set products apart.
Join our Director of Business Development, Bruce Ernest, next week in Boston, MA, June 16-19 for the Bio International Convention! Request a meeting with Bruce here: enableinjections.com/contact-us/ #BioInternational #drugdelivery #enFuse
Thank you to everyone who visited our booth at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting! Read more about data presented at ASCO featuring the enFuse technology in this Fierce Pharma article: bit.ly/3ZNwt1c #enFuse #ASCO2025 #subcutaneousdelivery
New positive data presented at #ASCO25 and published in @JCO_ASCO analyzed our enFuse drug delivery technology with an investigational subcutaneous #MultipleMyeloma combination therapy. Read the full @Sanofi press release: bit.ly/4dOlSJh
At Enable, we’re working to shift the narrative about large-volume subcutaneous delivery through education and data. Our VP of Medical Affairs Mehul Desai sat down with pharmaphorum to discuss recent survey findings. Read more: lnkd.in/gqeZCTKt #drugdelivery #enFuse
Join us at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting next week in Chicago, Illinois, May 30 - June 3! Visit Booth 17152 to learn more about the innovative enFuse drug delivery system or request a meeting: lnkd.in/eKacC7Xp #ASCO #drugdelivery #enFuse
United States Trends
- 1. TOP CALL 3,618 posts
- 2. #BaddiesUSA 64.7K posts
- 3. #centralwOrldXmasXFreenBecky 473K posts
- 4. SAROCHA REBECCA DISNEY AT CTW 493K posts
- 5. AI Alert 1,272 posts
- 6. #LingOrmDiorAmbassador 254K posts
- 7. Rams 29.8K posts
- 8. Market Focus 2,434 posts
- 9. Check Analyze N/A
- 10. Token Signal 1,713 posts
- 11. #LAShortnSweet 23.6K posts
- 12. Vin Diesel 1,534 posts
- 13. Scotty 10.3K posts
- 14. #MondayMotivation 6,680 posts
- 15. Chip Kelly 9,064 posts
- 16. Ahna 7,752 posts
- 17. Raiders 67.9K posts
- 18. sabrina 64.3K posts
- 19. DOGE 176K posts
- 20. Stacey 23.1K posts
Something went wrong.
Something went wrong.